Ophthalmology Therapeutics Market Reviewed in New Cutting-Edge Report Published by MarketPublishers.com

Share Article

The global ophthalmology market is expected to increase from last year’s USD 10.3 billion to USD 13.2 billion by 2017, growing at 3.6% CAGR. New report “Ophthalmology Therapeutics Market to 2017 - Protein Kinase Inhibitors and Prostaglandin H-Synthase Inhibitors to Drive Diabetic Retinopathy Market” prepared by GBI Research has been recently published by Market Publishers Ltd.

marketpublishers.com

Market Publishers Ltd

The global ophthalmology market is expected to increase from last year’s USD 10.3 billion to USD 13.2 billion by 2017, growing at 3.6% CAGR. The introduction of new molecules, which are currently in the regulatory filing stage as well as in the later stages of development, will drive the market growth.

New report “Ophthalmology Therapeutics Market to 2017 - Protein Kinase Inhibitors and Prostaglandin H-Synthase Inhibitors to Drive Diabetic Retinopathy Market” prepared by GBI Research has been recently published by Market Publishers Ltd.

Report Details:

Title: Ophthalmology Therapeutics Market to 2017 - Protein Kinase Inhibitors and Prostaglandin H-Synthase Inhibitors to Drive Diabetic Retinopathy Market
Published: October, 2011
Pages: 156
Price: US$ 3,500.00
http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/healthcare_equipment_services/ophthalmology_therapeutics_market_to_2017_protein_kinase_inhibitors_n_prostaglandin_h_synthase_inhibitors_to_drive_diabetic_retinopathy_market.html

The report provides true insights into the current and future state of the world ophthalmology therapeutics market, detailing six therapeutic indications of ophthalmology - glaucoma, allergic conjunctivitis, dry eye syndrome, diabetic macular edema, diabetic retinopathy and wet age macular degeneration. It examines global ophthalmology treatment usage patterns for the aforementioned indications and gives insights into the ophthalmology therapeutics R&D product pipeline. Furthermore, drivers and restrains, competitive landscape, key M&A activities and licensing agreements are also featured.

Report Contents:

1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 GLOBAL OPHTHALMOLOGY MARKET - INTRODUCTION

2.1 Overview
2.2 GBI Research Report Guidance

3 GLOBAL OPHTHALMOLOGY MARKET - MARKET CHARACTERIZATION

3.1 Introduction
3.2 Revenue Forecast for the Global Ophthalmology Market
3.2.1 Revenues
3.2.2 Annual Cost of Treatment (ACT)
3.3 Branded and Generic Market Share
3.4 Treatment Usage Patterns
3.4.1 Diseased Population
3.4.2 Treatment Seeking Population
3.4.3 Diagnosed Population
3.4.4 Prescription Population

4 GLOBAL OPHTHALMOLOGY MARKET - GEOGRAPHICAL LANDSCAPE

4.1 The US
4.1.1 Revenue
4.1.2 Annual Cost of Treatment
4.1.3 Treatment Usage Pattern
4.2 Top Five European Countries
4.2.1 Revenues of the Top Five European Countries
4.2.2 Annual Cost of Treatment
4.2.3 Treatment Usage Pattern
4.3 Japan
4.3.1 Revenues
4.3.2 Annual Cost of Treatment
4.3.3 Treatment Usage Pattern

5 GLOBAL OPHTHALMOLOGY MARKET - GLAUCOMA THERAPEUTICS MARKET

5.1 Introduction
5.2 Global Market Forecasts
5.3 Annual Cost of Treatment
5.4 Branded and Generic Market Share
5.5 Treatment Flow Algorithm
5.6 Treatment Usage Patterns
5.7 Market Forecasts for The US
5.8 Market Forecasts for the Top Five European Countries
5.9 Market Forecasts for Japan
5.10 Drivers of the Glaucoma Market
5.10.1 Increasing Prevalence of Eye Diseases
5.10.2 Improved Diagnosis of the Disease
5.11 Restraints for Glaucoma Market
5.11.1 Lower Awareness and Treatment Seeking Rates
5.11.2 Patent Expiry of Major Glaucoma Drugs such as Xalatan and Alphagan will Result in Negative Growth

6 GLOBAL OPHTHALMOLOGY MARKET - ALLERGIC CONJUNCTIVITIS

6.1 Introduction
6.1.1 Seasonal Allergic Conjunctivitis (SAC)
6.1.2 Perennial Allergic Conjunctivitis (PAC)
6.2 Market Forecasts
6.3 Annual Cost of Treatment
6.4 Branded and Generic Market Share
6.5 Treatment Flow Algorithm
6.6 Treatment Usage Patterns
6.7 Market Forecasts for the US
6.8 Market Forecasts for the Top Five European Countries
6.9 Market Forecasts for Japan
6.10 Drivers of Allergic Conjunctivitis Market
6.10.1 Increasing Awareness
6.11 Restraints for Allergic Conjunctivitis Market
6.11.1 Series of Patent Expires will Result in Slower Market Growth

7 GLOBAL OPHTHALMOLOGY MARKET - WET AGE MACULAR DEGENERATION

7.1 Introduction
7.2 Global Market Forecasts
7.3 Annual Cost of Treatment
7.4 Branded and Generic Market Share

Reports Examining Other Medicine, Pharmaceuticals & Biotechnology Markets are also Available:

  • Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers
  • Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
  • Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future
  • HIV/AIDS Therapeutics Market to 2017 - Superior Combination Therapies and Decreasing Mortality to Sustain Market Growth Despite Major Patent Expiries
  • Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value

More new reports by the publisher can be found at GBI Research page.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tanya Rezler
Visit website